InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Morgan Adam. Director active across 2 companies, notably HERON THERAPEUTICS, INC. /DE/. In total, 10 disclosures have been published. Split: 3 buys · 0 sell. Total volume traded: €7.5m. History available since 22 February 2023. The latest transaction was filed on 30 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Morgan Adam is a declarant and appears as a director at HERON THERAPEUTICS, INC. /DE/ and Alimera Sciences INC. There are 8 filings in total, and across the 8 sampled filings the reported buy volume is EUR 5257890 and the reported sell volume is EUR 0, over the period from 2023-02-24 to 2025-02-04, with the dominant transaction nature listed as Attribution.